Back to search

Article

Precise Control of Switchable Chimeric Antigen Receptor T Cells Allows Enhanced Safety and Less T Cell Exhaustion

2025-12-10

Abstract excerpt

<h4>Background</h4> Chimeric antigen receptor (CAR)-T cell therapies have achieved remarkable success in hematologic malignancies, yet their clinical utility remains limited by safety concerns, limited persistence, and T-cell exhaustion driven by continuous receptor signaling. While switchable CAR designs provide external control, many reported systems are irreversible, strictly binary, or compromise CAR-T potenc...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
939a1207-bd69-5067-9c20-b67747601ce8
DOI
10.64898/2025.12.07.692875
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Precise Control of Switchable Chimeric Antigen Receptor T Cells Allows Enhanced Safety and Less T Cell ExhaustionDOI 10.64898/2025.12.07.692875
Select a neighboring publication to make it the new centre.